Apogossypol Derivatives as Pan-Active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins-Reference-Cited by-同舟云学术

Apogossypol Derivatives as Pan-Active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins

Published:2009-06-25 Issue:14 Volume:52 Page:4511-4523
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wei Jun¹,Kitada Shinichi¹,Rega Michele F.¹,Stebbins John L.¹,Zhai Dayong¹,Cellitti Jason¹,Yuan Hongbin¹,Emdadi Aras¹,Dahl Russell¹,Zhang Ziming¹,Yang Li¹,Reed John C.¹,Pellecchia Maurizio¹

Affiliation:

1. Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm900472s

Reference44 articles.

1. Cell Death in Development

2. Dysregulation of Apoptosis in Cancer

3. Apoptosis

4. Apoptosis-based therapies

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer;European Journal of Pharmacology;2023-04

2. AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma;Cancers;2023-01-12

3. Practical Strategy to 1,1′-Dideoxygossypol Derivatives from Gossypol and Its Antitumor Activities;ACS Omega;2022-06-22

4. Structure, properties of gossypol and its derivatives—from physiological activities to drug discovery and drug design;Natural Product Reports;2022

5. Therapeutics targeting BCL2 family proteins;Mechanisms of Cell Death and Opportunities for Therapeutic Development;2022